Skip to content

Public FDA record

Z-2273-2024: ALPHAMAXX Mobile Operating Table, Model Number/Part Number: 113322F5

Recall record Z-2273-2024 for Getinge Usa Sales Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2273-2024
Company in FDA record
Getinge Usa Sales Inc
FDA classification date
Jul 5, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The recall is prompted by a defective charger unit (0970.2873) for models 1133.22B4, 1133.22B5, and 1133.22F5 of the ALPHAMAXX mobile operating table. This issue poses a risk of inadequate charging and operational failure.

Source facts

Action
On May 29, 2024 URGENT MEDICAL DEVICE CORRECTION letters were sent to customers. Actions to be taken by the Customer: Our records indicate that you have received one or more of the ALPHAMAXX Mobile Operating Table from the affected Product Code/Part Number 1133.22F5. Please examine your inventory immediately to determine if you have any of the ALPHAMAXX Mobile Operating Table (1133.22F5) with the Product REF number listed in this notice. The device can be used in accordance with the instructions for use, with extra attention to the following: 1. The battery status is displayed on the override panel of the operating table (IFU113322XYEN18_01 - 4.3 Override control panel). This is visible to the user at any time. 2. It is pointed out in the instruction for use (IFU113322XYEN18_01 5.2.4 Battery operation) that the operating table should be charged when the battery status is low. Whether or not you have affected product(s) with the Product REF numbers, please complete, and sign the attached MEDICAL DEVICE CORRECTION RESPONSE FORM to acknowledge that you have received this notification. Return the completed form to Getinge by e-mailing a scanned copy to maquet.gmbhalphamaxx.sw.qrc@getinge.com or by faxing the form to 1- 866- 575- 5658. Please forward this information to all current and potential ALPHAMAXX Mobile Operating Table users within your hospital/facility. If you are a distributor who has shipped any affected products to customers, please forward this document to their attention for appropriate action. Type of Action by Maquet/Getinge: *Maquet/Getinge has developed a solution that will correct this issue. A Getinge Service Representative will contact you to schedule the correction. This work will be done at no cost to your facility. Adverse reactions or quality problems experienced with the use of any of the products identified on Pages 1 and 2 may be reported to the FDA s MedWatch Adverse Event Reporting program either online, by regular mail or by fax usi
Initiated
2024-05-29
Root cause
Component design/selection
Distribution
Domestic: KY, NC, NY, VA. International: Australia, Bulgaria, Croatia, Czech Republic, Denmark, France, Greece, Hong Kong, Ireland, Israel, Japan, Jordan, Kuwait, Mexico, New Zealand, Norway, Poland, Romania, Saudi Arabia, South Africa, Spain, Switzerland, Thailand, United Arab Emirates, United Kingdom.
Recall number
Z-2273-2024
Recall status
Open, Classified
CDRH record ID
208158
FDA classified
2024-07-05
Recall event number
94740

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗